The company will spin off the Bausch + Lomb Brand into a fully integrated, pure play eye-health company, and incorporate its other eye health product offerings into the new company.
Bausch Health will then focus on its gastroenterology, aesthetics/dermatology, neurology and pharmaceuticals businesses.
Company leadership said it wanted to spin the company off to “better enable stakeholders to value each business independently.”
More articles on specialty centers:
ASC considers in-house alternative to ‘overwhelmed’ hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs
